Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?

NCT02207686 is registered in ClinicalTrials.gov with Marie Luise Bisgaard, MD as lead sponsor.

NCT NCT02207686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02207686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
Lead sponsor
Marie Luise Bisgaard, MD
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2014
Completion date
August 31, 2017
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

von hippel-lindaus disease